In this Issue
By Robert L. Avery, MD; and Allen C. Ho, MD;
Volunteer-based missions bring ophthalmologists the chance to offer their skills to those in need.
By Rachel M. Renshaw, Editor-in-Chief
Business of Retina
By George A. Williams, MD
By Aron Shapiro; Maureen O’Connell; and Ryan Bouchard
Pearls for managing a variety of surgical scenarios.
By Manish Nagpal, MS, DO, FRCS(UK)
The efficacy of natural dyes in ocular surgery is under investigation.
By Eduardo A. Novais, MD; Eduardo B. Rodrigues, MD; Magno Antonio Ferreira, MD; ane Chen, MD; André Maia, MD; Maurício Maia, MD; Emmerson Badaró, MD; Fernando M. Penha, MD; and Michel Eid Farah, MD
By Spenser J. Morton, BS; Priya Sharma, BS; and Carol L. Shields, MD
Ocriplasmin has been evaluated in children in a phase 2 trial; results have not been announced.
By Kimberly Drenser, MD, PhD
This lifelong disease requires prompt treatment and vigilant follow-up.
By Franco M. Recchia, MD
A remote screening program can leverage the efforts of a single skilled screener.
By Darius M. Moshfeghi, MD
Papillophlebitis in a Young Girl Secondary to Homozygous Mutation of MTHFR C677T and A1298C Genotypes
By Kiran Turaka, MD; Matthew C. Ziemianski, MD; and J. Shepard Bryan, MD
Some promising results with VEGF inhibition, but laser remains the standard of care.
By Michael T. Trese, MD
Special Cover Features: Medical Innovation in Retina
In addition to its effects in DME, this molecule can induce posterior vitreous detachment.
By Baruch D. Kuppermann, MD, PhD
Anti-PDGF Combination Therapy in Neovascular Age-related Macular Degeneration: Results of a Phase 2b Study
By Pravin U. Dugel, MD
New pharmacologic treatment option is an alternative to surgery or watchful waiting.
By David S. Boyer, MD
Dr. Trese is a Clinical Professor of Ophthalmology at The Eye Research Institute of Oakland University, a Clinical Associate Professor at Wayne State University School of Medicine, and the Chief of Pediatric and Adult Vitreoretinal Surgery at William Beaumont Hospital in Michigan.